Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label(Part1), Single Arm(Part1), Randomized(Part2), Double-blind(Part2), Active-controlled(Part2), Phase III Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children

NCT02541253 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT02541253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02541253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label(Part1), Single Arm(Part1), Randomized(Part2), Double-blind(Part2), Active-controlled(Part2), Phase III Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2015
Completion date
June 30, 2016
Enrollment
543 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

influenza